Exenatide (Byetta) Vs Pramlintide (Symlin): Role in Post-Prandial Hyperglycemia.
Phase of Trial: Phase III
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Exenatide (Primary) ; Pramlintide (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 13 Jun 2017 Status changed from recruiting to completed, based on the results presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
- 08 Dec 2010 Additional lead trial centre/investigator identified as reported by ClinicalTrials.gov.